Viatris VTRS Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net Sales by Business | |||||
| Developed Markets Segment | $8.55B-4.6% | $8.96B-3.4% | $9.28B-5.2% | $9.79B-6.1% | |
| Emerging Markets Segment | $2.22B-1.9% | $2.26B-11.8% | $2.56B-2.8% | $2.64B-16.1% | |
| Greater China | $2.33B+7.6% | $2.17B+0.3% | $2.16B-1.9% | $2.2B-0.5% | |
| Japan, Australia and New Zealand Segment | $1.2B-11.3% | $1.35B-5.3% | $1.43B-12.7% | $1.63B-19.4% | |
| Net Sales by Product | |||||
| Brands | $9.18B-0.2% | $9.2B-6.1% | $9.8B-0.9% | $9.89B-8.8% | |
| Celebrex ® | $272.9M-4.4% | $285.6M-13.6% | $330.6M-2.2% | $338M-1.9% | |
| Creon ® | $365.8M+11.5% | $328.2M+7.6% | $304.9M+0.3% | $304M-1.9% | |
| Dymista ® | $163.6M-13.0% | $188M-6.0% | $200M+11.2% | $179.9M+7.1% | |
| Effexor ® | $257.7M+1.9% | $252.9M-3.8% | $262.9M-6.0% | $279.6M-11.7% | |
| EpiPen® Auto-Injectors | $469.7M+19.8% | $392M-11.4% | $442.2M+17.0% | $378M-3.5% | |
| Generics | $5.07B-7.8% | $5.49B-1.7% | $5.59B-11.7% | $6.33B-9.2% | |
| Lipitor | $1.55B+5.5% | $1.47B-5.8% | $1.56B-4.6% | $1.64B-1.7% | |
| Lyrica ® | $487M-1.7% | $495.4M-11.0% | $556.5M-10.8% | $623.9M-14.4% | |
| Norvasc | $709.9M+5.4% | $673.3M-8.1% | $732.4M-5.5% | $775.1M-6.0% | |
| Viagra ® | $408.2M+3.2% | $395.6M-7.7% | $428.8M-6.6% | $458.9M-14.0% | |
| Xalabrands | $158.4M-4.8% | $166.4M-13.9% | $193.2M-1.0% | $195.1M-13.7% | |
| Xanax ® | $139.9M-3.5% | $145M-6.3% | $154.8M-1.1% | $156.5M-15.8% | |
| Yupelri ® | $266.9M+11.9% | $238.5M+8.0% | $220.8M+9.2% | $202.2M+24.9% | |
| Zoloft ® | $254.9M+8.1% | $235.7M0.0% | $235.7M-4.3% | $246.2M-13.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Viatris break its business down?
- Viatris (VTRS) reports net sales by business across 4 parts — Developed Markets Segment, Emerging Markets Segment, Greater China and Japan, Australia and New Zealand Segment. Each is extracted from the segment footnotes and tracked over time.
- Where does Viatris's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Viatris's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
